CASE STUDY ― The Rapid Development of CBD Formulations From Scratch for a New OTC Product


Case Study - CannabidiolAltasciences has become the go-to partner for pharmaceutical companies striving to develop safe and effective cannabidiol (CBD) products to address unmet medical needs. With our integrated early phase drug development solutions, we can quickly undertake formulation development and clinical manufacturing of next generation formulations with challenging APIs and controlled substances, such as CBD.

In this latest case study, our client (Emyria) presented the challenge of developing several oral formulation candidates for CBD from scratch for a new over-the-counter (OTC) product. Learn how we completed the entire project in just over three months!


You may also be interested in: 

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.